Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer

Minimal Residual Disease Detection using a Plasma-Only Circulating Tumor DNA Assay in Colorectal Cancer Patients

(2021) Aparna R. Parikh et al.   CLINICAL CANCER RESEARCH

Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

(2020) G. Argiles et al.   ANNALS OF ONCOLOGY

Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer

(2019) Thomas Reinert et al.   JAMA Oncology

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

(2019) Jeanne Tie et al.   JAMA Oncology

RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study

(2018) J B Bachet et al.   ANNALS OF ONCOLOGY

Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer–Specific Mortality in Patients With Stage II or III Colorectal Cancer

(2018) Peer Wille-Jørgensen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma

(2015) G. Rosati et al.   ANNALS OF ONCOLOGY

Incidence and patterns of late recurrences in colon cancer patients

(2015) Anne-Marie Bouvier et al.   INTERNATIONAL JOURNAL OF CANCER

Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer

(2014) John N. Primrose et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Intensive Radiographic and Biomarker Surveillance in Stage II and III Colorectal Cancer

(2012) Ahmad Fora et al.   ONCOLOGY